Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:acetaminophenStrength |
325 mg
|
| gptkbp:activeIngredient |
gptkb:oxycodone
acetaminophen |
| gptkbp:broadcastOn |
Schedule II controlled substance (US)
|
| gptkbp:contraindication |
acute or severe bronchial asthma
severe respiratory depression |
| gptkbp:features |
do not combine with alcohol
may impair mental or physical abilities |
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pro-325
|
| gptkbp:manufacturer |
gptkb:Procare_PharmacyCare
|
| gptkbp:oxycodoneStrength |
varies (commonly 5 mg, 7.5 mg, or 10 mg)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:riskFactor |
addiction
overdose |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
constipation drowsiness respiratory depression |
| gptkbp:usedFor |
pain relief
|
| gptkbp:bfsParent |
gptkb:PDP-11
|
| gptkbp:bfsLayer |
6
|